CN100374565C - 用于epothilone生物合成的基因 - Google Patents

用于epothilone生物合成的基因 Download PDF

Info

Publication number
CN100374565C
CN100374565C CNB998074217A CN99807421A CN100374565C CN 100374565 C CN100374565 C CN 100374565C CN B998074217 A CNB998074217 A CN B998074217A CN 99807421 A CN99807421 A CN 99807421A CN 100374565 C CN100374565 C CN 100374565C
Authority
CN
China
Prior art keywords
seq
nucleotide
amino acid
epothilone
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998074217A
Other languages
English (en)
Chinese (zh)
Other versions
CN1305530A (zh
Inventor
T·斯彻普
J·M·利根
I·莫尔纳
R·泽克尔
J·戈拉彻
D·西尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN1305530A publication Critical patent/CN1305530A/zh
Application granted granted Critical
Publication of CN100374565C publication Critical patent/CN100374565C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CNB998074217A 1998-06-18 1999-06-16 用于epothilone生物合成的基因 Expired - Fee Related CN100374565C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US09/099,504 1998-06-18
US10163198P 1998-09-24 1998-09-24
US60/101,631 1998-09-24
US11890699P 1999-02-05 1999-02-05
US60/118,906 1999-02-05

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CNB2004100637938A Division CN100374566C (zh) 1998-06-18 1999-06-16 用于epothilone生物合成的基因
CNA2007100890997A Division CN101161817A (zh) 1998-06-18 1999-06-16 用于epothilone生物合成的基因

Publications (2)

Publication Number Publication Date
CN1305530A CN1305530A (zh) 2001-07-25
CN100374565C true CN100374565C (zh) 2008-03-12

Family

ID=27378840

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998074217A Expired - Fee Related CN100374565C (zh) 1998-06-18 1999-06-16 用于epothilone生物合成的基因

Country Status (16)

Country Link
EP (1) EP1088078A2 (ko)
JP (3) JP2002518004A (ko)
KR (1) KR100511233B1 (ko)
CN (1) CN100374565C (ko)
AU (1) AU753567B2 (ko)
BR (1) BR9911349A (ko)
CA (1) CA2329774A1 (ko)
HU (1) HUP0102186A3 (ko)
ID (1) ID29128A (ko)
IL (3) IL139735A0 (ko)
NO (2) NO20006195L (ko)
NZ (1) NZ508326A (ko)
PL (1) PL200157B1 (ko)
SK (1) SK19242000A3 (ko)
TR (1) TR200003759T2 (ko)
WO (1) WO1999066028A2 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
JP4662635B2 (ja) 1998-11-20 2011-03-30 コーサン バイオサイエンシーズ, インコーポレイテッド エポチロンおよびエポチロン誘導体を生成するための組換え方法および材料
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
ATE309369T1 (de) * 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
IL155306A0 (en) 2000-10-13 2003-11-23 Univ Mississippi Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
US7767399B2 (en) * 2005-01-31 2010-08-03 Merck & Co., Inc. Purification process for plasmid DNA
DK2668284T3 (en) 2011-01-28 2014-12-15 Amyris Inc Screening of colony micro encapsulated in gel
MX2013013065A (es) 2011-05-13 2013-12-02 Amyris Inc Metodos y composiciones para detectar la produccion microbiana de compuestos inmiscibles em agua.
BR112015002724B1 (pt) 2012-08-07 2022-02-01 Total Marketing Services Método para produzir um composto não catabólico heterólogo, e, composição de fermentação
BR112015023089A2 (pt) 2013-03-15 2017-11-21 Amyris Inc célula hospedeira, método para produzir um isoprenoide, e método para aumentar a produção de acetil-coa ou um composto derivado de acetil-coa
CN105934517A (zh) 2013-08-07 2016-09-07 阿迈瑞斯公司 用于稳定生产乙酰辅酶a衍生化合物的方法
AU2016284689B9 (en) 2015-06-25 2022-01-20 Amyris, Inc. Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022461A1 (de) * 1996-11-18 1998-05-28 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022461A1 (de) * 1996-11-18 1998-05-28 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A Sorangium cellulosum (Myxobacterium) Gene Cluster for theBiosynthesis of the Macrolide antibiotic soraphenA:Cloning,characterization,and homology to polyketidesynthase genes from actinomycetes. Thomas Schupp et al.Journal of Bacteriology,Vol.177 No.13. 1995 *
Towards the synthesis of epothilone A:enantioselectivepreparation of the thiazole sidechain and macrocyclic ringclosure. Richard E et al.Tetrahedron Letters,Vol.38 No.12. 1997 *

Also Published As

Publication number Publication date
IL139735A0 (en) 2002-02-10
HUP0102186A2 (hu) 2001-10-28
KR100511233B1 (ko) 2005-08-31
NZ508326A (en) 2003-10-31
NO20006195L (no) 2001-02-16
IL190391A0 (en) 2008-11-03
WO1999066028A3 (en) 2000-06-29
AU4611699A (en) 2000-01-05
WO1999066028A2 (en) 1999-12-23
CN1305530A (zh) 2001-07-25
TR200003759T2 (tr) 2001-06-21
PL345579A1 (en) 2001-12-17
NO20091055L (no) 2001-02-16
BR9911349A (pt) 2001-03-13
HUP0102186A3 (en) 2005-10-28
JP2008092958A (ja) 2008-04-24
JP2002518004A (ja) 2002-06-25
ID29128A (id) 2001-08-02
IL139735A (en) 2009-06-15
KR20010052962A (ko) 2001-06-25
CA2329774A1 (en) 1999-12-23
AU753567B2 (en) 2002-10-24
PL200157B1 (pl) 2008-12-31
JP2006061166A (ja) 2006-03-09
SK19242000A3 (sk) 2001-07-10
NO20006195D0 (no) 2000-12-06
EP1088078A2 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
US6346404B1 (en) Genes for the biosynthesis of epothilones
CN100374565C (zh) 用于epothilone生物合成的基因
AU753546B2 (en) Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents
DK2271666T3 (da) Nrps-pks-gengruppe og dens manipulation og anvendelighed
TWI291464B (en) Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
CN1227362C (zh) 生产刺糖噻杀虫剂所用的生物合成基因
KR20100049580A (ko) 티오펩티드 전구체 단백질, 그를 코딩하는 유전자 및 그의 용도
US20050208620A1 (en) Compositions and methods for hydroxylating epothilones
CN100374566C (zh) 用于epothilone生物合成的基因
TWI770070B (zh) 經修飾之抗真菌鏈黴菌(streptomyces fungicidicus)分離株及其用途
CZ20004693A3 (cs) Izolovaná nukleová kyselina kódující polypeptid účastnící se biosyntézy epothilonu, chimérický gen, vektor a hostitelské buňky obsahující tuto nukleovou kyselinu
MXPA00012342A (en) Genes for the biosynthesis of epothilones
KR20050050146A (ko) 글리코펩티드 항생제 a40926의 생합성을 위한 유전자및 단백질
RU2265054C2 (ru) Рекомбинантная клетка-хозяин (варианты) и клон вас
RU2234532C2 (ru) Нуклеиновая кислота (варианты), ее использование для экспрессии эпотилонов, полипептид (варианты), клон бактерий е.coli
CN100359014C (zh) 一类新型埃坡霉素化合物及其制备方法和用途
CN1311820A (zh) 得自粘膜炎莫拉氏菌的basb027蛋白和basb027基因、抗原、抗体及应用
Julien et al. Genetic Engineering of Myxobacterial Natural Product Biosynthetic Genes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NOVARTIS CO., LTD.

Free format text: FORMER NAME: NOVARTIS AG

CP01 Change in the name or title of a patent holder

Address after: Basel

Patentee after: Novartis Ag

Address before: Basel

Patentee before: Novartis AG

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080312

Termination date: 20140616

EXPY Termination of patent right or utility model